Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545700 · ClinicalTrials.gov registry record · Phase 4
Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery
A Phase 4 study, sponsored by Endeavor Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT01545700: Completed Phase 4 study, sponsored by Endeavor Health.
NCT01545700 is a Phase 4 study that has completed, run by Endeavor Health. The registered enrollment target is 200 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01545700, a Phase 4 study, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
The question of a possible hyperglycemic effect from single-dose dexamethasone is an important issue for clinicians managing patients in the intraoperative and postoperative periods. Recent evidence suggests that even moderate elevations in blood glucose levels may be associated with adverse events. The aim of this clinical investigation is to determine whether standard clinical doses of dexamethasone produce hyperglycemia in the perioperative period.
Primary Outcome
Serum blood glucose concentrations
Interventions
- DRUG Control-saline
- DRUG Dexamethasone 4 mg
- DRUG Dexamethasone 8 mg
- DRUG Control saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
What the finished NCT01545700 record still lists
NCT01545700 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 4 interventions - of which Control-saline is the first listed.
NCT01545700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01545700 about?
NCT01545700 is a clinical study titled "Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery". The question of a possible hyperglycemic effect from single-dose dexamethasone is an important issue for clinicians managing patients in the intraoperative and postoperative periods. Recent evidence suggests that even moderate elevations in blood glucose levels may be associated with adverse events....
What is the current status of trial NCT01545700?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2009-09. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01545700?
The interventions under investigation include: Control-saline (DRUG), Dexamethasone 4 mg (DRUG), Dexamethasone 8 mg (DRUG), Control saline (DRUG).
Who is sponsoring clinical trial NCT01545700?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01545700's enrollment target sits among peer trials
200 407th of 2000 higher than 1,556 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia